NBI-1117570 is an investigational oral, dual muscarinic M1/M4 selective receptor agonist discovered by Nxera advancing through clinical ...

Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone ...

BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...

There is growing demand for treatments that can safely prevent and reverse bone loss over time. Osteoporosis, a condition that weakens bones and makes ...

A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression ...

The accelerated cellular aging and altered gene activity in early-onset colorectal cancer, when not caused by inherited ...

What is the Cnpy1 protein? New research reveals how the Canopy1 protein allows vomeronasal neurons to survive high ER-stress.

Hyderabad, have identified a mammalian protein, Cnpy1 (Canopy1), that is essential for the survival and function of ...

I ate 1,000 sardines in a month and two bizarre things happened: I smelled and obtained a strange superpower. New science ...

Eli Lilly and Company LLY, last week, gained the much-anticipated FDA approval for its once-daily oral GLP-1 pill ...